Back to search

Article

Targeting Rab-RILPL Interactions as a Strategy to Downregulate Pathogenic LRRK2 in Parkinson’s Disease

2023-11-06

Abstract excerpt

<h4>ABSTRACT</h4> Familial Parkinson’s disease (PD) is frequently linked to multiple disease-causing mutations within Leucine-Rich Repeat Protein Kinase 2 (LRRK2), leading to aberrant kinase activity. Multiple pathogenic effects of enhanced LRRK2 activity have been identified including loss of cilia and centrosomal cohesion defects. When phosphorylated by LRRK2, Rab8a and Rab10 bind to phospho-specific RILPL effe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5506d9d6-23fe-5c6e-872c-c09d4bfefb12
DOI
10.1101/2023.11.06.565863
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting Rab-RILPL Interactions as a Strategy to Downregulate Pathogenic LRRK2 in Parkinson’s DiseaseDOI 10.1101/2023.11.06.565863
Select a neighboring publication to make it the new centre.